Mackenzie Financial Corp Care Dx, Inc. Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$28.19 - $46.6 $158,596 - $262,171	-5,626 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $26,903 - $48,060	653 Added 13.13%	5,626 $256,000
Q3 2021 Nov 08, 2021	BUY	$59.15 - $91.99 $83,401 - $129,705	1,410 Added 39.57%	4,973 $315,000
Q2 2021 Aug 11, 2021	BUY	$63.02 - $95.11 $224,540 - $338,876	3,563 New	3,563 $326,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.